200 related articles for article (PubMed ID: 19527301)
1. The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.
Blazejewski S; Georges A; Forest K; Corcuff JB; Abouelfath A; Girodet PO; Kamagate M; Jacquet A; Pillet O; Bordenave L; Moore N
Fundam Clin Pharmacol; 2009 Jun; 23(3):339-44. PubMed ID: 19527301
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
[TBL] [Abstract][Full Text] [Related]
3. Effects of alcohol and liver cirrhosis on the GH-IGF-I axis.
Santolaria F; González-González G; González-Reimers E; Martínez-Riera A; Milena A; Rodgíguez-Moreno F; González-García C
Alcohol Alcohol; 1995 Nov; 30(6):703-8. PubMed ID: 8679009
[TBL] [Abstract][Full Text] [Related]
4. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
Ham JN; Ginsberg JP; Hendell CD; Moshang T
Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
[TBL] [Abstract][Full Text] [Related]
7. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.
Priego T; Ibáñez de Cáceres I; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E50-6. PubMed ID: 13129855
[TBL] [Abstract][Full Text] [Related]
8. Changes in total ghrelin within the somatotropic axis in severe burn patients: comparison of those with inhalation injury and those without inhalation injury.
Lee BW; Park SH; Ihm SH; Kim JH; Kim DH; You KC; Kim SW; Yoo HJ
Growth Horm IGF Res; 2008 Aug; 18(4):291-7. PubMed ID: 18178497
[TBL] [Abstract][Full Text] [Related]
9. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.
Ehrnborg C; Ohlsson C; Mohan S; Bengtsson BA; Rosén T
Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
11. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.
Garcia JM; Polvino WJ
Growth Horm IGF Res; 2009 Jun; 19(3):267-73. PubMed ID: 19196529
[TBL] [Abstract][Full Text] [Related]
13. Effect of lycopene supplementation on insulin-like growth factor-1 and insulin-like growth factor binding protein-3: a double-blind, placebo-controlled trial.
Graydon R; Gilchrist SE; Young IS; Obermüller-Jevic U; Hasselwander O; Woodside JV
Eur J Clin Nutr; 2007 Oct; 61(10):1196-200. PubMed ID: 17299493
[TBL] [Abstract][Full Text] [Related]
14. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
15. Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?
Yuen KC; Bennett RM; Hryciw CA; Cook MB; Rhoads SA; Cook DM
Growth Horm IGF Res; 2007 Feb; 17(1):82-8. PubMed ID: 17289417
[TBL] [Abstract][Full Text] [Related]
16. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
[TBL] [Abstract][Full Text] [Related]
17. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
[TBL] [Abstract][Full Text] [Related]
18. Effects of the IGF-I/IGFBP-3 complex on GH and ghrelin nocturnal concentrations in low birth weight children.
Iñiguez G; Salazar T; Roman R; Avila A; Gunn RD; Cassorla F
Clin Endocrinol (Oxf); 2006 Nov; 65(5):687-92. PubMed ID: 17054474
[TBL] [Abstract][Full Text] [Related]
19. IGF-I does not affect the net increase in GH release in response to arginine.
Nass R; Pezzoli SS; Chapman IM; Patrie J; Hintz RL; Hartman ML; Thorner MO
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E702-10. PubMed ID: 12217887
[TBL] [Abstract][Full Text] [Related]
20. Effects of cadmium and zinc on plasma levels of growth hormone, insulin-like growth factor I, and insulin-like growth factor-binding protein 3.
Turgut S; Kaptanoglu B; Turgut G; Emmungil G; Genç O
Biol Trace Elem Res; 2005; 108(1-3):197-204. PubMed ID: 16327072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]